Abeona Therapeutics is led by Vishwas Soman, who serves as the Chief Executive Officer, guiding the clinical-stage biopharmaceutical company's operational strategy and regulatory interactions. Bringing significant executive and financial leadership experience within the life sciences industry, he oversees the company's ongoing efforts to develop and commercialize advanced cell and gene therapies designed to treat severe, life-threatening rare genetic diseases.